PTEN and Neural Regeneration
Releasing the brake on axon growth in the injured central nervous system
Mature nerve cells in the brain, spinal cord, and optic nerve barely regrow their axons after injury. One reason is PTEN: it holds down the mTOR growth program that neurons switch off as they mature. Remove that brake, and some axons grow again.
Why the adult CNS does not regenerate
A developing neuron extends a long axon with ease. As it matures, it shuts down that growth machinery — useful for a stable adult brain, costly after injury. When an adult central-nervous-system axon is severed, the neuron largely fails to restart protein synthesis and growth, and the connection is lost for good.
PTEN is the brake
PTEN keeps mTOR — a master regulator of protein synthesis and cell growth — turned down, by erasing the PIP3 signal (see the PI3K/Akt/mTOR pathway). In 2008, Zhigang He’s lab showed that deleting PTEN in retinal ganglion cells reactivates mTOR and drives robust optic-nerve regeneration after injury — the landmark result that put PTEN at the centre of this field.
Building on the landmark
- Co-deleting PTEN and SOCS3 produces sustained, longer-distance axon regeneration than either alone.
- Combining PTEN loss with visual activity and growth factors achieved full-length optic-nerve regrowth and partial recovery of simple visual behaviours in mice.
- Later work maps the wiring more precisely: AKT is the hub, acting through mTORC1 and GSK3β, with STAT3 helping sustain long-distance growth.
The optic nerve as the test bed
The optic nerve — the axons of retinal ganglion cells — is the classic model, because it is pure central nervous system tissue that is straightforward to injure and image. That is why PTEN sits at the centre of vision-restoration research specifically.
This is preclinical, and mostly mouse genetics. Even when axons regrow, they struggle to reconnect to the correct targets in the brain, so PTEN manipulation does not yet restore useful vision in people. It defines the target; it is not a therapy.
Beyond the optic nerve
The same logic has been tested in spinal-cord and corticospinal injury models, where PTEN deletion likewise improves axon regrowth. Across these systems the message is consistent: PTEN restrains an intrinsic growth program, and lifting that restraint is necessary — but not sufficient — for functional repair.
Studying it in the lab
Researchers probe this biology by lowering PTEN with PTEN siRNA or blocking its activity with the inhibitor SF1670, and by tracking the protein with an anti-PTEN antibody. Supplied for laboratory research use only.
Frequently asked questions
Why is PTEN studied in nerve regeneration?
Because PTEN is the intrinsic brake on axon growth. It keeps the mTOR growth program off in mature neurons, and removing it lets injured central-nervous-system axons regrow — first shown in the optic nerve.
Does deleting PTEN restore vision?
In mice, deleting PTEN drives strong optic-nerve axon regrowth, and combinations can restore simple visual behaviours. It is not a human therapy: regrown axons still struggle to reconnect correctly to the brain, which remains the unsolved step.
Is PTEN inhibition a treatment for spinal cord injury?
Not yet. PTEN deletion improves axon regeneration in preclinical spinal-cord and corticospinal models, but no PTEN-based treatment is approved for human spinal cord injury.
What other pathways work with PTEN here?
Regeneration is combinatorial. SOCS3/STAT3, AKT, GSK3β and the mTOR program all contribute, which is why single-gene manipulation alone rarely gives full functional recovery.
Key references
- 1.Park KK, Liu K, Hu Y, et al. “Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.” Science. 2008. DOI ↗
- 2.Sun F, Park KK, Belin S, et al. “Sustained axon regeneration induced by co-deletion of PTEN and SOCS3.” Nature. 2011. DOI ↗
- 3.de Lima S, Koriyama Y, Kurimoto T, et al. “Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors.” PNAS. 2012. DOI ↗
- 4.Trends in Pharmacological Sciences (review). “Emerging therapeutic strategies for optic nerve regeneration.” Trends in Pharmacological Sciences. 2024.
Continue reading
Related research reagents
Tools for studying PTEN in the lab — research use only.
Educational content based on peer-reviewed research — not medical advice. Reagents are supplied for laboratory research use only and are not for human or veterinary use.